Indivior Pharmaceuticals, Inc. Number Of Instruments That Are Antidilutive In Period Presented
Indivior Pharmaceuticals, Inc. (INDV) reported Number Of Instruments That Are Antidilutive In Period Presented of 810.00 thousand shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-06.
Discontinued › Notes › Shares
ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented · last filed 2024-03-06
| Period end | Number Of Instruments That Are Antidilutive In Period Presented 12 month |
|---|---|
| 2023-12-31 | 810.00K shares 20-F · filed 2024-03-06 |
| 2022-12-31 | 0.00 shares 20-F · filed 2024-03-06 |
| 2021-12-31 | 485.00K shares 20-F · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |